Skip to main content
. 2002 Sep;129(3):541–548. doi: 10.1046/j.1365-2249.2002.01933.x

Fig. 4.

Fig. 4

Increase in HLA-DR+ T cells in BALF in DM/PM patients with corticosteroid-resistant and corticosteroid-sensitive IP. BALF cells from DM/PM patients with corticosteroid-resistant IP (n = 6) and corticosteroid-sensitive IP (n = 16) and from controls without IP (n = 12) were stained with (a) anti-CD4-FITC and (b) anti-CD8-PerCP, and anti-HLA-DR-PE antibodies and analysed by FACS. • DM patients, ▪ PM patients, ▴ lung cancer patients without IP. *P < 0·001.